HomeMarketsSharesSabra Health Care REIT Inc

Trade Sabra Health Care REIT Inc - SBRA CFD

Market is not available at the momentMarket information is presented
as of 2026-10-16T19:47:47+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.07
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02224 %
(-$4.45)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02224%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00001 %
($0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


0.00001%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close19.25
Open19.15
1-Year Change9.12%
Day's Range19.15 - 19.49

Trade Sabra Health Care REIT Inc - SBRA

About Sabra Health Care REIT Inc

Sabra Health Care REIT, Inc. is a self-administered, self-managed real estate investment trust (REIT). The Company through its subsidiaries, owns and invests in real estate serving the healthcare industry. Its primary business consists of acquiring, financing, and owning real estate property to be leased to third-party tenants in the healthcare sector. It is engaged in leasing properties to tenants and owning properties operated by third-party property managers throughout the United States and Canada. The Company’s investment portfolio comprises of skilled nursing/transitional care facilities, senior housing communities and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements; investments in loans receivable; and preferred equity investments.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Sabra Health Care REIT Inc revenues decreased 5% to $569M. Net loss totaled $113.3M vs. income of $138.4M. Revenues reflect NAREIT FFO - Per Share - Diluted - Total decrease of 31% to $1.15, Fixed Charge Coverage Ratio, Total decrease of 2% to 5.03, Rental and related revenues decrease of 8% to $396.7M.

Equity composition

Common Stock $0.01 Par, 4/11, 125B auth., 25,0092,591 issd. Insiders own 1%.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready